Lance Dworkin investigates the pathogenesis of progression of chronic kidney disease, including factors that modulate renal fibrosis and scarring, and renal inflammation, which are invariable findings in kidneys progressing to end stage renal failure. He is also the study chair for the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial, a large multicenter randomized clinical trial funded by the National Heart, Lung, and Blood Institute (NHLBI) that is examining the best therapy for patients with hypertension due to atherosclerotic renal vascular disease.
Lance D. Dworkin, M.D., is Professor of Medicine, Vice Chairman of Medicine for Research, Academic Affairs and Ethics, and Director of the Division of Kidney Disease & Hypertension at Brown Medical School. He earned his undergraduate degree at Yale and his M.D. degree at the University of Pennsylvania. He completed residency training and was chief medical resident at New York University/Bellevue Hospital. He trained in nephrology at Brigham & Women's Hospital, Harvard University. He was Associate Professor of Medicine and Associate Medical Director of the Clinical Research Center at New York University until 1993 when he moved to Brown. Dr. Dworkin conducts research on the mechanisms of progressive kidney failure and its prevention and on the treatment of renovascular hypertension. He is the author of over 100 original articles, reviews, book chapters and has been an invited lecturer at numerous academic medical centers and scientific meetings in the United States and abroad.
LANCE DWORKIN, MD
Collaborators at other institutions:
Are you Lance Dworkin? Click here to edit your research profile.